COVID-19

A Ph.D.’s Open Letter to Elected Representatives

To My State and Federal Government Representatives, The current push to market the COVID-19 therapies as vaccines against SARs-Cov-2 by the various Representatives and Senators in Washington is troubling.  Both therapies have no proven ability to prevent a disease and carry a high level of adverse health effects (including death).  Approval by FDA, unlike Emergency

A Ph.D.’s Open Letter to Elected Representatives Read More »

ICAN ASKS FDA about SAFETY OF LIPID NANOPARTICLES in COVID-19 Vaccines

Important news from the Informed Consent Action Network (ICAN) ICAN, through its attorneys, has once again written to Dr. Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research, to demand a response to the question of whether or not lipid nanoparticles used in both of the currently authorized COVID-19 vaccines are safe.

ICAN ASKS FDA about SAFETY OF LIPID NANOPARTICLES in COVID-19 Vaccines Read More »